The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability

Stacey M. Anderson, Eyal Dassau, Dan Raghinaru, John Lum, Sue A. Brown, Jordan E. Pinsker, Mei Mei Church, Carol Levy, David Lam, Yogish C Kudva, Bruce Buckingham, Gregory P. Forlenza, R. Paul Wadwa, Lori Laffel, Francis J. Doyle, J. Hans Devries, Eric Renard, Claudio Cobelli, Federico Boscari, Simone Del FaveroBoris P. Kovatchev

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Use of artificial pancreas (AP) requires seamless interaction of device components, such as continuous glucose monitor (CGM), insulin pump, and control algorithm. Mobile AP configurations also include a smartphone as computational hub and gateway to cloud applications (e.g., remote monitoring and data review and analysis). This International Diabetes Closed-Loop study was designed to demonstrate and evaluate the operation of the inControl AP using different CGMs and pump modalities without changes to the user interface, user experience, and underlying controller. Methods: Forty-three patients with type 1 diabetes (T1D) were enrolled at 10 clinical centers (7 United States, 3 Europe) and 41 were included in the analyses (39% female, >95% non-Hispanic white, median T1D duration 16 years, median HbA1c 7.4%). Two CGMs and two insulin pumps were tested by different study participants/sites using the same system hub (a smartphone) during 2 weeks of in-home use. Results: The major difference between the system components was the stability of their wireless connections with the smartphone. The two sensors achieved similar rates of connectivity as measured by percentage time in closed loop (75% and 75%); however, the two pumps had markedly different closed-loop adherence (66% vs. 87%). When connected, all system configurations achieved similar glycemic outcomes on AP control (73% [mean] time in range: 70-180 mg/dL, and 1.7% [median] time <70 mg/dL). Conclusions: CGMs and insulin pumps can be interchangeable in the same Mobile AP system, as long as these devices achieve certain levels of reliability and wireless connection stability.

Original languageEnglish (US)
Pages (from-to)73-80
Number of pages8
JournalDiabetes Technology and Therapeutics
Volume21
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Artificial Pancreas
Insulin
Type 1 Diabetes Mellitus
Equipment and Supplies
Glucose
Smartphone

Keywords

  • Continuous glucose monitor use
  • Insulin pump use
  • International Diabetes Closed-Loop Study

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Anderson, S. M., Dassau, E., Raghinaru, D., Lum, J., Brown, S. A., Pinsker, J. E., ... Kovatchev, B. P. (2019). The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability. Diabetes Technology and Therapeutics, 21(2), 73-80. https://doi.org/10.1089/dia.2018.0308

The International Diabetes Closed-Loop Study : Testing Artificial Pancreas Component Interoperability. / Anderson, Stacey M.; Dassau, Eyal; Raghinaru, Dan; Lum, John; Brown, Sue A.; Pinsker, Jordan E.; Church, Mei Mei; Levy, Carol; Lam, David; Kudva, Yogish C; Buckingham, Bruce; Forlenza, Gregory P.; Wadwa, R. Paul; Laffel, Lori; Doyle, Francis J.; Hans Devries, J.; Renard, Eric; Cobelli, Claudio; Boscari, Federico; Del Favero, Simone; Kovatchev, Boris P.

In: Diabetes Technology and Therapeutics, Vol. 21, No. 2, 01.02.2019, p. 73-80.

Research output: Contribution to journalArticle

Anderson, SM, Dassau, E, Raghinaru, D, Lum, J, Brown, SA, Pinsker, JE, Church, MM, Levy, C, Lam, D, Kudva, YC, Buckingham, B, Forlenza, GP, Wadwa, RP, Laffel, L, Doyle, FJ, Hans Devries, J, Renard, E, Cobelli, C, Boscari, F, Del Favero, S & Kovatchev, BP 2019, 'The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability', Diabetes Technology and Therapeutics, vol. 21, no. 2, pp. 73-80. https://doi.org/10.1089/dia.2018.0308
Anderson, Stacey M. ; Dassau, Eyal ; Raghinaru, Dan ; Lum, John ; Brown, Sue A. ; Pinsker, Jordan E. ; Church, Mei Mei ; Levy, Carol ; Lam, David ; Kudva, Yogish C ; Buckingham, Bruce ; Forlenza, Gregory P. ; Wadwa, R. Paul ; Laffel, Lori ; Doyle, Francis J. ; Hans Devries, J. ; Renard, Eric ; Cobelli, Claudio ; Boscari, Federico ; Del Favero, Simone ; Kovatchev, Boris P. / The International Diabetes Closed-Loop Study : Testing Artificial Pancreas Component Interoperability. In: Diabetes Technology and Therapeutics. 2019 ; Vol. 21, No. 2. pp. 73-80.
@article{9a9ff16eeb9d4dbda8f23ae000635cd6,
title = "The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability",
abstract = "Background: Use of artificial pancreas (AP) requires seamless interaction of device components, such as continuous glucose monitor (CGM), insulin pump, and control algorithm. Mobile AP configurations also include a smartphone as computational hub and gateway to cloud applications (e.g., remote monitoring and data review and analysis). This International Diabetes Closed-Loop study was designed to demonstrate and evaluate the operation of the inControl AP using different CGMs and pump modalities without changes to the user interface, user experience, and underlying controller. Methods: Forty-three patients with type 1 diabetes (T1D) were enrolled at 10 clinical centers (7 United States, 3 Europe) and 41 were included in the analyses (39{\%} female, >95{\%} non-Hispanic white, median T1D duration 16 years, median HbA1c 7.4{\%}). Two CGMs and two insulin pumps were tested by different study participants/sites using the same system hub (a smartphone) during 2 weeks of in-home use. Results: The major difference between the system components was the stability of their wireless connections with the smartphone. The two sensors achieved similar rates of connectivity as measured by percentage time in closed loop (75{\%} and 75{\%}); however, the two pumps had markedly different closed-loop adherence (66{\%} vs. 87{\%}). When connected, all system configurations achieved similar glycemic outcomes on AP control (73{\%} [mean] time in range: 70-180 mg/dL, and 1.7{\%} [median] time <70 mg/dL). Conclusions: CGMs and insulin pumps can be interchangeable in the same Mobile AP system, as long as these devices achieve certain levels of reliability and wireless connection stability.",
keywords = "Continuous glucose monitor use, Insulin pump use, International Diabetes Closed-Loop Study",
author = "Anderson, {Stacey M.} and Eyal Dassau and Dan Raghinaru and John Lum and Brown, {Sue A.} and Pinsker, {Jordan E.} and Church, {Mei Mei} and Carol Levy and David Lam and Kudva, {Yogish C} and Bruce Buckingham and Forlenza, {Gregory P.} and Wadwa, {R. Paul} and Lori Laffel and Doyle, {Francis J.} and {Hans Devries}, J. and Eric Renard and Claudio Cobelli and Federico Boscari and {Del Favero}, Simone and Kovatchev, {Boris P.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1089/dia.2018.0308",
language = "English (US)",
volume = "21",
pages = "73--80",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - The International Diabetes Closed-Loop Study

T2 - Testing Artificial Pancreas Component Interoperability

AU - Anderson, Stacey M.

AU - Dassau, Eyal

AU - Raghinaru, Dan

AU - Lum, John

AU - Brown, Sue A.

AU - Pinsker, Jordan E.

AU - Church, Mei Mei

AU - Levy, Carol

AU - Lam, David

AU - Kudva, Yogish C

AU - Buckingham, Bruce

AU - Forlenza, Gregory P.

AU - Wadwa, R. Paul

AU - Laffel, Lori

AU - Doyle, Francis J.

AU - Hans Devries, J.

AU - Renard, Eric

AU - Cobelli, Claudio

AU - Boscari, Federico

AU - Del Favero, Simone

AU - Kovatchev, Boris P.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Background: Use of artificial pancreas (AP) requires seamless interaction of device components, such as continuous glucose monitor (CGM), insulin pump, and control algorithm. Mobile AP configurations also include a smartphone as computational hub and gateway to cloud applications (e.g., remote monitoring and data review and analysis). This International Diabetes Closed-Loop study was designed to demonstrate and evaluate the operation of the inControl AP using different CGMs and pump modalities without changes to the user interface, user experience, and underlying controller. Methods: Forty-three patients with type 1 diabetes (T1D) were enrolled at 10 clinical centers (7 United States, 3 Europe) and 41 were included in the analyses (39% female, >95% non-Hispanic white, median T1D duration 16 years, median HbA1c 7.4%). Two CGMs and two insulin pumps were tested by different study participants/sites using the same system hub (a smartphone) during 2 weeks of in-home use. Results: The major difference between the system components was the stability of their wireless connections with the smartphone. The two sensors achieved similar rates of connectivity as measured by percentage time in closed loop (75% and 75%); however, the two pumps had markedly different closed-loop adherence (66% vs. 87%). When connected, all system configurations achieved similar glycemic outcomes on AP control (73% [mean] time in range: 70-180 mg/dL, and 1.7% [median] time <70 mg/dL). Conclusions: CGMs and insulin pumps can be interchangeable in the same Mobile AP system, as long as these devices achieve certain levels of reliability and wireless connection stability.

AB - Background: Use of artificial pancreas (AP) requires seamless interaction of device components, such as continuous glucose monitor (CGM), insulin pump, and control algorithm. Mobile AP configurations also include a smartphone as computational hub and gateway to cloud applications (e.g., remote monitoring and data review and analysis). This International Diabetes Closed-Loop study was designed to demonstrate and evaluate the operation of the inControl AP using different CGMs and pump modalities without changes to the user interface, user experience, and underlying controller. Methods: Forty-three patients with type 1 diabetes (T1D) were enrolled at 10 clinical centers (7 United States, 3 Europe) and 41 were included in the analyses (39% female, >95% non-Hispanic white, median T1D duration 16 years, median HbA1c 7.4%). Two CGMs and two insulin pumps were tested by different study participants/sites using the same system hub (a smartphone) during 2 weeks of in-home use. Results: The major difference between the system components was the stability of their wireless connections with the smartphone. The two sensors achieved similar rates of connectivity as measured by percentage time in closed loop (75% and 75%); however, the two pumps had markedly different closed-loop adherence (66% vs. 87%). When connected, all system configurations achieved similar glycemic outcomes on AP control (73% [mean] time in range: 70-180 mg/dL, and 1.7% [median] time <70 mg/dL). Conclusions: CGMs and insulin pumps can be interchangeable in the same Mobile AP system, as long as these devices achieve certain levels of reliability and wireless connection stability.

KW - Continuous glucose monitor use

KW - Insulin pump use

KW - International Diabetes Closed-Loop Study

UR - http://www.scopus.com/inward/record.url?scp=85060912327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060912327&partnerID=8YFLogxK

U2 - 10.1089/dia.2018.0308

DO - 10.1089/dia.2018.0308

M3 - Article

C2 - 30649925

AN - SCOPUS:85060912327

VL - 21

SP - 73

EP - 80

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 2

ER -